logo
episode-header-image
May 2024
38m 36s

Episode 104: Colorectal Cancer Series, P...

Rouleaux University Medical Center
About this episode

We have another guest joining us this week! Dr. Allison Schepers, PharmD, BCOP is a Clinical Pharmacist Specialist at the Rogel Cancer Center at the University of Michigan where she focuses on GI, GU, and Thoracic malignancies! In this episode, Allison discusses the high yield points we need to know about important drugs we use in the colorectal cancer treatment space and how she approaches counseling her patients. Another great episode from our pharmacy colleagues you do NOT want to miss!

Content:

- Important considerations about capecitabine, oxaliplain, and irinotecan, backbones of our colorectal cancer management

- An overview of targeted agents?

- If someone has a reaction, can we retrial any of these drugs in the future?

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

Up next
Sep 17
Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)
This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we highly recommend listening to part 3 of our follicular lymphoma series. You may al ... Show More
36m 11s
Sep 10
Episode 138: Follicular Lymphoma Series, Pt 3 - Relapsed/Refractory Management (non-cellular therapy options)
This week, we shift our focus to talking about relapsed/refractory follicular lymphoma. In this episode, we will specifically discuss treatment options other than cellular therapy, which will be an upcoming episode. If you have not done so, we highly recommend listening to part 1 ... Show More
29m 51s
Jun 2025
Episode 137: Follicular Lymphoma Series, Pt 2. - Front-line Management
This week, we continue our conversation on follicular lymphoma, this time focusing on front line therapy. We discuss how we approach localized and diffuse disease and the data behind why we do what we do. Episode contents:- What is the front-line approach to management for locali ... Show More
30m 11s
Recommended Episodes
Jul 2024
Precision Medicine in Myelodysplastic Syndromes (MDS)
Join us on this podcast episode featuring Prof. Maria Teresa Voso (Tor Vergata University of Rome, Italy) as she offers her insights on the latest advancements in precision medicine for diagnosing and treating myelodysplastic syndromes (MDS). In this interview with our EHA host, ... Show More
17m 45s
Apr 2024
Precision Medicine in Follicular Lymphoma
Join us for this captivating interview with our guest Prof Stefano Luminari, MD, PhD, from the University of Modena and Reggio Emilia in Italy, as he explores what precision medicine means today for follicular lymphoma. Together with our host Dr. Isabel Olivera-Martinez, they dis ... Show More
19m 46s
May 2024
Ep 37: Talking with patients about sad, bad and difficult things
This is Episode 37 of PsychCrunch, the podcast of the British Psychological Society’s Research Digest, sponsored by Routledge Psychology. [Content warning: This episode centres around cancer. As such, it makes references to medical events and themes that some listeners may find d ... Show More
42m 8s
Sep 4
Colorectal Cancer
Ninja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob discuss Colorectal Cancer. This comprehensive discussion focuses on the clinical presentation, pathogenesis, and management of one of the most common malignancies encountered in clinical practice.We start by brea ... Show More
37m 25s
Dec 2024
139. Back to Basics - Early HER2 Breast Cancer
Human epidermal growth factor receptor 2 (HER2) is overexpressed in multiple cancers, including breast, gastric, colorectal, and epithelial ovarian cancers. However, this receptor's complexity doesn't stop there. It has multiple subdomains and various responses to drugs, and the ... Show More
24m 31s
Jan 2025
Episode 109: The Silent Crisis: Burnout in the Medical Field
Listen to this latest episode of the podcast cohosted with MohammadAli Jardaly, with Dr. Alaa Rihan, a Family Medicine physician and a scholar, Leading Physician Wellbeing Program with the American Academy of Family Physicians. Burnout affects more than 50% of physicians in the U ... Show More
29m 11s
Sep 26
Sep 26 2025 This Week in Cardiology
A bold trial in valvular heart disease, a CV prevention trial whose message is humility, VTE dogma challenged, more news on oral GLP-1 agonists, and a few public service announcements are the topics John Mandrola, MD, discusses in this week’s podcast. This podcast is intended for ... Show More
22m 50s
Jun 2025
Jun 27 2025 This Week in Cardiology
FDA approves triple-drug polypill, a change of opinion, a deep dive into invasive pulmonary embolism therapies, heart disease trends, and diabetes care is on fire are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professio ... Show More
28m 58s
Sep 4
BITESIZE | 3 Simple Dietary Tips to Improve Your Gut Health, Boost Your Energy & Reduce Inflammation | Dr Emily Leeming #575
Twenty years ago, very few scientists even knew about something called the gut microbiome. Now, with over 70,000 research papers published on the subject, this complex ecosystem, home to trillions of microorganisms, is recognised as a key factor in our physical and mental wellbei ... Show More
22m 28s
Dec 2024
Non-Muscle Invasive Bladder Cancer Basics with Dr. Kyle Richards
Our guest is Dr. Kyle Richards, a urologic oncologist and Associate Professor in the Department of Urology at the University of Wisconsin. He talks with us about the basics around non-muscle invasive bladder cancer. Learn about common symptoms, diagnosis and treatment options to ... Show More
12m 52s